Theradaptive

We’re excited to announce that Theradaptive will be attending and presenting at LSI USA ‘25, the premier event for MedTech innovation and collaboration this March. Make sure to connect with our CEO, Dr. Luis Alvarez, as he joins industry leaders at this unparalleled partnering event. Let’s shape the future of healthcare together! #LSIUSA25 #MedTech #HealthTech #Innovation #LifeSciences #TechForHealth #Biotech #Networking #MedicalDevices #FutureOfHealthcare

Very proud of our team and thankful for the State of Maryland!

We're thrilled to announce that our Phase I/II OASIS clinical trial has expanded to Maryland, with two patients recently treated at MedStar Health by Dr. David Weiner. This marks a major step forward in the evaluation of OsteoAdapt™ SP for spinal fusion, bringing us closer to transforming treatment for degenerative spine conditions. In addition, we’re honored to receive a $1 million grant from the Maryland Stem Cell Research Fund (MSCRF) to support our current and future manufacturing and clinical developments.   A huge thank you to Dr. David Weiner and the team at MedStar Health for their invaluable contributions to the trial, and to Maryland Stem Cell Research Fund (MSCRF) for supporting our mission to revolutionize regenerative medicine to address unmet medical needs. #Theradaptive #Biotech #RegenerativeMedicine #ClinicalTrials #SpinalFusion #OsteoAdapt #MedTech #MedicalInnovation #LifeSciences #Orthopedics #BoneRegeneration #HealthcareInnovation #GMPManufacturing #MSCRF #MarylandBiotech #SurgicalAdvancements #FutureOfMedicine #Biotechnology Read more in our press release linked here:

Let's meet at JPM 2025!

FDA approved our OASIS study expansion to ALIF & LLIF & 3X study sites! Learn more about it here: https://lnkd.in/gPy9NZjC Learn about OASIS here: https://lnkd.in/e-vQKEBs

Very proud of our collaboration with Drs. David Schwartz MD, MBA and M Craig McMains of OrthoIndy. They led the way with the first two patients treated in our OASIS trial.

We’re excited to share the publication of our latest study in Spine, featuring an in-depth evaluation of our lead product, OsteoAdapt, in an ovine spinal interbody fusion model. The results are truly compelling: OsteoAdapt, driven by our breakthrough technology, demonstrated faster bone formation and bone density compared with native bone. This sets the stage for a new benchmark in spinal fusion. This achievement brings us one step closer to making autograft obsolete, with significant potential for massive clinical impact and cost reduction to the healthcare system. Explore the full study to learn more about these transformative findings! #SpineResearch #Orthopedics #InnovationInBiotech #SpineResearch #InnovationInBiotech #BoneRegeneration #SyntheticGraft #SpinalFusion #NextGenMedicine #ClinicalBreakthrough

Theradaptive is proud to announce that our lead product OsteoAdapt™ SP has received the Gold Level Award for Best Technology in Spine 2024 from Orthopedics This Week! This prestigious award acknowledges OsteoAdapt™ SP as a best-in-class product candidate that delivers targeted bone-forming protein biologics with unmatched precision in complex spine surgeries. We extend our heartfelt thanks to the distinguished panel of surgeons for this honor and to our dedicated team for their hard work. (Read the full release here: https://lnkd.in/eNJ9xWxm)    #Theradaptive #OsteoAdaptSP #Innovation #SpineSurgery #Awards #Healthcare #ClinicalTrials #Biologics #PatientCare #MedicalDevices #Orthopedics #Research #DrugDevelopment #LifeSciences

We’d like to extend a heartfelt thank you to everyone who came out to support the ribbon-cutting of our new facility in #Frederick! Your presence made the day incredibly special as we celebrated this exciting milestone together.   This new space represents a significant leap forward as we navigate our clinical trials, bringing our groundbreaking protein-engineering technology to the forefront of regenerative medicine. We’re excited about what’s ahead and couldn’t have made it here without the support of our partners and the vibrant biotech community in Frederick.   A sincere thank you to the Maryland Stem Cell Research Fund (MSCRF), Frederick Innovative Technology Center, Inc (FITCI), VaLogic Bio, Maryland Tech Council, and the Frederick County Office of Economic Development for their unwavering commitment to our journey.   Here’s to the future of innovation and the partnerships that make it all possible!